Axine Signs Multimillion-Dollar Wastewater Service Agreement with a Global Pharmaceutical Company
Contract reinforces industry commitment to mitigate the impact of pharmaceuticals in the environment
VANCOUVER, BC,
Under terms of the agreement, Axine will design, build, own, and remotely operate a turnkey treatment system at an eastern
"This agreement is a significant milestone for Axine as we work to expand acceptance in the pharmaceutical industry," said
In recent years, the pharmaceutical industry has made progress in reducing APIs in wastewater discharged to the environment from manufacturing operations. While APIs are not currently regulated, policy initiatives are underway in
Axine has created a new standard for treating virtually any complex or challenging organic pollutant in pharmaceutical wastewater by combining breakthrough technology with a modular system and service business model. Systems are based on Axine's proprietary electrochemical oxidation technology, which uses advanced catalysts and electricity to oxidize and destroy a wide range of organic pollutants so the treated water can be safely discharged or reused.
Adds Rhone, "Our business model creates long-term partnerships with our customers while minimizing their capital investment and risk. By treating wastewater at the source and reusing the treated water where possible, we're also helping customers reduce both water consumption and environmental impacts in a cost-competitive manner."
The service agreement was signed after the completion of a comprehensive treatability test program conducted at Axine's
About
Axine has created a new standard for treating toxic organic pollutants in wastewater for customers in the pharmaceutical, chemical, and other industries to address a global problem. Axine's breakthrough solution combines advanced electrochemical oxidation technology with a flexible, modular system design capable of treating the widest range of organic pollutants with the highest performance and lowest cost. Axine's unique wastewater-as-a-service business model enables customers to achieve wastewater and sustainability goals with minimal capital investment and technology risk. For more information, please visit www.axinewater.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/axine-signs-multimillion-dollar-wastewater-service-agreement-with-a-global-pharmaceutical-company-301188859.html
SOURCE
Elsevier acquires Shadow Health, a leading provider of best-in-class healthcare simulations
Inspiration for Ruthie's Law forgotten by investor of nursing home where she died
Advisor News
- Woman charged with targeting South Florida Haitian community in $4.6 million Ponzi scheme
- Making the most of Financial Planning Month
- Study shows most retirees are financially fragile – and how advisors can help
- 20% of DIY investors continue to rely on financial professionals, study finds
- Ramesh Ponnuru: The moral case for higher interest rates
More Advisor NewsAnnuity News
Health/Employee Benefits News
- Nevada's public health insurance option could bring more than $1B in savings
- Are Medicare supplements and Medicare Advantage plans the same?
- Pa. bill could ease insurance OK for new treatments
- HEALTH CARE;Are supplements, Medicare Advantage PPO plans the same?
- Dan Walters: Pressure builds for workers’ compensation overhaul
More Health/Employee Benefits NewsLife Insurance
- ACLI names 2023 chair and board of directors
- ACLI conference wraps up with a look at 2023’s regulatory landscape
- Insurers must reimagine work, ACLI speaker says
- Addressing the 2 most common objections to buying life insurance
- Former House Speaker Paul Ryan headlines ACLI 2022 conference
More Life Insurance